Manulife (Manufacturers Life Insurance)’s Theravance Biopharma TBPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$174K Buy
15,747
+1,020
+7% +$11.3K ﹤0.01% 2612
2025
Q1
$132K Sell
14,727
-705
-5% -$6.3K ﹤0.01% 2626
2024
Q4
$145K Sell
15,432
-179
-1% -$1.68K ﹤0.01% 2728
2024
Q3
$126K Sell
15,611
-1,012
-6% -$8.16K ﹤0.01% 2799
2024
Q2
$141K Sell
16,623
-2,431
-13% -$20.6K ﹤0.01% 2728
2024
Q1
$171K Sell
19,054
-450
-2% -$4.04K ﹤0.01% 2651
2023
Q4
$219K Sell
19,504
-4,294
-18% -$48.3K ﹤0.01% 2575
2023
Q3
$205K Hold
23,798
﹤0.01% 2589
2023
Q2
$246K Sell
23,798
-356
-1% -$3.69K ﹤0.01% 2483
2023
Q1
$262K Hold
24,154
﹤0.01% 2388
2022
Q4
$271K Sell
24,154
-386
-2% -$4.33K ﹤0.01% 2374
2022
Q3
$249K Sell
24,540
-447
-2% -$4.53K ﹤0.01% 2423
2022
Q2
$226K Buy
24,987
+724
+3% +$6.56K ﹤0.01% 2577
2022
Q1
$232K Sell
24,263
-6,970
-22% -$66.6K ﹤0.01% 2673
2021
Q4
$345 Sell
31,233
-2,640
-8% -$29 ﹤0.01% 2515
2021
Q3
$251K Buy
33,873
+4,082
+14% +$30.2K ﹤0.01% 2807
2021
Q2
$433K Buy
29,791
+3,755
+14% +$54.6K ﹤0.01% 2542
2021
Q1
$531K Sell
26,036
-1,533
-6% -$31.3K ﹤0.01% 2231
2020
Q4
$490K Buy
27,569
+1,436
+5% +$25.5K ﹤0.01% 2205
2020
Q3
$386K Sell
26,133
-568
-2% -$8.39K ﹤0.01% 2129
2020
Q2
$551K Sell
26,701
-2,327
-8% -$48K ﹤0.01% 1915
2020
Q1
$671K Buy
29,028
+3,394
+13% +$78.5K ﹤0.01% 1688
2019
Q4
$709K Sell
25,634
-1,108
-4% -$30.6K ﹤0.01% 1853
2019
Q3
$520K Sell
26,742
-284
-1% -$5.52K ﹤0.01% 1992
2019
Q2
$441K Sell
27,026
-452
-2% -$7.38K ﹤0.01% 2125
2019
Q1
$623K Buy
27,478
+129
+0.5% +$2.93K ﹤0.01% 1962
2018
Q4
$700K Sell
27,349
-264
-1% -$6.76K ﹤0.01% 1780
2018
Q3
$902K Sell
27,613
-3,880
-12% -$127K ﹤0.01% 1874
2018
Q2
$714K Buy
31,493
+655
+2% +$14.9K ﹤0.01% 2111
2018
Q1
$748K Sell
30,838
-126
-0.4% -$3.06K ﹤0.01% 2033
2017
Q4
$864K Buy
30,964
+222
+0.7% +$6.2K ﹤0.01% 1945
2017
Q3
$1.05M Sell
30,742
-479
-2% -$16.4K ﹤0.01% 1755
2017
Q2
$1.24M Buy
31,221
+1,175
+4% +$46.8K ﹤0.01% 1675
2017
Q1
$1.11M Buy
30,046
+4,355
+17% +$160K ﹤0.01% 1689
2016
Q4
$819K Buy
25,691
+1,734
+7% +$55.3K ﹤0.01% 1774
2016
Q3
$868K Buy
23,957
+44
+0.2% +$1.59K ﹤0.01% 1724
2016
Q2
$543K Buy
23,913
+5,888
+33% +$134K ﹤0.01% 1978
2016
Q1
$332K Buy
18,025
+1,407
+8% +$25.9K ﹤0.01% 2245
2015
Q4
$273 Buy
16,618
+352
+2% +$6 ﹤0.01% 2427
2015
Q3
$179 Buy
16,266
+315
+2% +$3 ﹤0.01% 2735
2015
Q2
$208 Buy
15,951
+750
+5% +$10 ﹤0.01% 2817
2015
Q1
$263 Buy
15,201
+483
+3% +$8 ﹤0.01% 2528
2014
Q4
$219 Buy
14,718
+99
+0.7% +$1 ﹤0.01% 2574
2014
Q3
$337 Buy
14,619
+43
+0.3% +$1 ﹤0.01% 2260
2014
Q2
$465K Buy
+14,576
New +$465K ﹤0.01% 2086